Skip to Content

ASE 9875 (Ledipasvir and Sofosbuvir 90 mg / 400 mg)

Pill with imprint ASE 9875 is Orange, Four-sided and has been identified as Ledipasvir and Sofosbuvir 90 mg / 400 mg.

Ledipasvir/sofosbuvir is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Ledipasvir/sofosbuvir 90 mg / 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ASE 9875

Ledipasvir and sofosbuvir 90 mg / 400 mg ASE 9875

Ledipasvir and Sofosbuvir

Imprint
ASE 9875
Strength
90 mg / 400 mg
Color
Orange
Shape
Four-sided
Availability
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Manufacturer
Asegua Therapeutics LLC
National Drug Code (NDC)
72626-2601

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.